首页|Geneva University Hospitals Reports Findings in Personalized Medicine (The role of biomarkers and dosimetry parameters in overall and progression free survival prediction for patients treated with personalized 90Y glass microspheres SIRT: a …)
Geneva University Hospitals Reports Findings in Personalized Medicine (The role of biomarkers and dosimetry parameters in overall and progression free survival prediction for patients treated with personalized 90Y glass microspheres SIRT: a …)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews Daily News – New research on Drugs and Therapies - Personalized Medicine is the subject of a report.According to news reporting or iginating in Geneva, Switzerland, by NewsRx journalists, research stated,“Overa ll Survival (OS) and Progression-Free Survival (PFS) analyses are crucial metric s for evaluatingthe efficacy and impact of treatment. This study evaluated the role of clinical biomarkers and dosimetryparameters on survival outcomes of pat ients undergoing Y selective internal radiation therapy (SIRT).”
GenevaSwitzerlandEuropeBiomarkersCyborgsDiagnostics and ScreeningDrugs and TherapiesEmerging TechnologiesHealth and MedicineMachine LearningPersonalized MedicinePersonalized Ther apy
NETL
NSTL
